BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28202010)

  • 1. On the censored cost-effectiveness analysis using copula information.
    Fontaine C; Daurès JP; Landais P
    BMC Med Res Methodol; 2017 Feb; 17(1):27. PubMed ID: 28202010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care.
    Wonderling D; Vickers AJ; Grieve R; McCarney R
    BMJ; 2004 Mar; 328(7442):747. PubMed ID: 15023830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies.
    Crespo C; Monleon A; Díaz W; Ríos M
    BMC Med Res Methodol; 2014 Dec; 14():139. PubMed ID: 25533141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite likelihood for joint analysis of multiple multistate processes via copulas.
    Diao L; Cook RJ
    Biostatistics; 2014 Oct; 15(4):690-705. PubMed ID: 24719283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian estimation of cost-effectiveness from censored data.
    Heitjan DF; Kim CY; Li H
    Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-parametric regression models for cost-effectiveness analysis: improving the efficiency of estimation from censored data.
    Pullenayegum EM; Willan AR
    Stat Med; 2007 Jul; 26(17):3274-99. PubMed ID: 17309112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copula based prediction models: an application to an aortic regurgitation study.
    Kumar P; Shoukri MM
    BMC Med Res Methodol; 2007 Jun; 7():21. PubMed ID: 17573974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using inverse-weighting in cost-effectiveness analysis with censored data.
    Willan AR; Lin DY; Cook RJ; Chen EB
    Stat Methods Med Res; 2002 Dec; 11(6):539-51. PubMed ID: 12516988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of acupuncture, counselling and usual care in treating patients with depression: the results of the ACUDep trial.
    Spackman E; Richmond S; Sculpher M; Bland M; Brealey S; Gabe R; Hopton A; Keding A; Lansdown H; Perren S; Torgerson D; Watt I; MacPherson H
    PLoS One; 2014; 9(11):e113726. PubMed ID: 25426637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian cost-effectiveness analysis for censored data: an application to antiplatelet therapy.
    Wu DB; Tsai YW; Wen YW
    J Med Econ; 2012; 15(3):434-43. PubMed ID: 22196038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian bivariate survival analysis using the power variance function copula.
    Romeo JS; Meyer R; Gallardo DI
    Lifetime Data Anal; 2018 Apr; 24(2):355-383. PubMed ID: 28536818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An information ratio-based goodness-of-fit test for copula models on censored data.
    Sun T; Cheng Y; Ding Y
    Biometrics; 2023 Sep; 79(3):1713-1725. PubMed ID: 36440608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copula based flexible modeling of associations between clustered event times.
    Geerdens C; Claeskens G; Janssen P
    Lifetime Data Anal; 2016 Jul; 22(3):363-81. PubMed ID: 26210669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating incremental cost-effectiveness ratios and their confidence intervals with differentially censored data.
    Wang H; Zhao H
    Biometrics; 2006 Jun; 62(2):570-5. PubMed ID: 16918922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependence modeling for recurrent event times subject to right-censoring with D-vine copulas.
    Barthel N; Geerdens C; Czado C; Janssen P
    Biometrics; 2019 Jun; 75(2):439-451. PubMed ID: 30549012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Average cost-effectiveness ratio with censored data.
    Bang H; Zhao H
    J Biopharm Stat; 2012; 22(2):401-15. PubMed ID: 22251182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A note on the estimation of confidence intervals for cost-effectiveness when costs and effects are censored.
    Blackhouse G; Briggs AH; O'Brien BJ
    Med Decis Making; 2002; 22(2):173-7. PubMed ID: 11958499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of acupuncture care as an adjunct to exercise-based physical therapy for osteoarthritis of the knee.
    Whitehurst DG; Bryan S; Hay EM; Thomas E; Young J; Foster NE
    Phys Ther; 2011 May; 91(5):630-41. PubMed ID: 21415230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression methods for cost-effectiveness analysis with censored data.
    Willan AR; Lin DY; Manca A
    Stat Med; 2005 Jan; 24(1):131-45. PubMed ID: 15515137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented composite likelihood for copula modeling in family studies under biased sampling.
    Zhong Y; Cook RJ
    Biostatistics; 2016 Jul; 17(3):437-52. PubMed ID: 26819481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.